LANXESS marks 40 yrs of animal disease defense 'Virkon S'
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The facility features 2,176 high-performance GPUs across the US and Europe
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications
The company announced positive topline data from the Phase 3 ADorable-1 trial
LTTS’ lung digital twin integrates seamlessly with CT imaging workflows, using deep learning to reconstruct a comprehensive 3D digital twin of the lungs
Subscribe To Our Newsletter & Stay Updated